# Global option for whether to use corrected age-at-detection distribution
CORRECT_BC_AGE <- TRUE

#Screening uptake
uptakefirstscreen<-0.625 #Uptake for the first screen
uptakeotherscreen<-0.887 #Uptake if woman has attended >=1 screen
uptakenoscreen<-0.208 #Uptake if woman has not previously attended screening

#Uptake for risk stratification
risk_uptake<-1 #Uptake for risk prediction
risk_feedback<-1 #Uptake for attending risk feedback consultation
screen_change<-1 #Uptake for changing screening intervals based on risk

#Age of an individual at start of simulation
start_age<-38 #Default is 38 to give time for tumours to develop pre-screening

#Set time horizon
time_horizon<-100

#Set health and cost discount rates
discount_health<-0.035
discount_cost<-0.035

##############Set clinical parameters for screening########################

#Set parameters of a Weibull survival curve to represent all cause mortality
acmmortality_wb_a<-9.38
#7.937
acmmortality_wb_b<-89.35
#86.788

#Set parameters for all cause mortality following breast cancer
gamma_survival_1<-exp(-5.618) #Exponential distribution scale parameter stage 1
gamma_survival_2<-exp(-3.808) #Exponential distribution scale parameter stage 2
gamma_survival_3<-exp(-2.731) #Exponential distribution scale parameter stage 3
gamma_stage <- c(gamma_survival_1,gamma_survival_2,gamma_survival_3)

# Expected population prevalence for doing Bayes correction
expected_prev <- .12

#Read in distribution of cancer incidence by age
Incidence_Mortality <- if (CORRECT_BC_AGE){
  read.csv("Data/Incidence_Mortality_ONS2.csv") %>%
  mutate(BC_age =
           expected_prev * Cond.on.getting.BC..prob.of.getting.cancer.at.age.t /
           (surv/surv[1])) %>%
  mutate(BC_age =
           replace(BC_age,
                   age == 100,
                   1-sum(BC_age[1:100])))
  }else{
  read.csv("Data/Incidence_Mortality_ONS2.csv") %>%
    mutate(BC_age = Cond.on.getting.BC..prob.of.getting.cancer.at.age.t)}

#Set metastatic cancer probabilities by age
metastatic_prob <- data.frame(c(25,35,45,55,65,75,85),
                              c(0.046218154,0.086659039,0.109768116,0.127099924,
                                0.142505975,0.159837783,1.73E-01))

#Create matrix of probability of cancer stage by cancer size
stage_by_size_mat<-data.frame("v1"=c(0.383,0.567,0.611,0.557,0,0),
                              "v2"=c(0.033,0.111,0.180,0.208,0.723,0.563),
                              "v3"=c(0.058,0.057,0.089,0.147,0.206,0.351),
                              "v5"=c(0.525,0.265,0.120,0.088,0.071,0.086))

#Set mean and sd of tumour doublings at clinical detection
clin_detection_m <- 6.5 
clin_detection_sd <- 0.535

#Mammography with sensitivity conditional on tumour diameter parameters
beta1 <- 1.47 
beta2 <- 6.51

#Mammography sensitivity by volpara density grade
VDG_interval<-c(4.5,7.5,15.5)
Sen_VDG <- c(0.75,0.735,0.598,0.513)
Sen_VDG_av <- 0.666

#Supplemental screening sensitivity parameters
Mammo_cdr <- 4.2 #Cancer detection rate per 1000 high dense screens
MRI_cdr <- 5 #CDR for MRI in Mammogram negative women (incremental)
US_cdr <- 3 #CDR for US in Mammogram negative women (incremental)

#Set tumour growth rate parameters
log_norm_mean <- 1.07
log_norm_sd <- 1.31
max_size <- 128 #Maximum size of tumours, mm diameter
start_size <- 0.25 #Starting size of tumours, diameter in mm
Vc = (4/3)*pi*(start_size/2)^3 #Volume at start
Vm = (4/3)*pi*(max_size/2)^3 #Max volume

#Metatstatic survival parameters
meta_survival_54 <- exp(-1.787) #Age <= 54
meta_survival_74 <- exp(-1.388) #Age 55-74
meta_survival_99 <- exp(-1.011) #Age 75+
metastatic_survival <- c(meta_survival_54, meta_survival_74, meta_survival_99)

#Set screening ages
screen_startage <- 50 #Starting age
screen_endage <- 70 #Ending age
high_risk_screentimes <- seq(screen_startage,screen_endage,1) #Yearly screening
med_risk_screentimes <- seq(screen_startage,screen_endage,2) #Two yearly screening
low_risk_screentimes <- seq(screen_startage,screen_endage,3) #Three yearly screening

#Set maximum screening sensitivity
sensitivity_max <- 0.95

#Risk cut-offs for different screening approaches
risk_cutoffs_procas <- c(1.5,3.5,5,8,100) #PROCAS and PROCAS Full
risk_cutoffs_tert <- c(1.946527,2.942792) #Tertiles of risk
low_risk_cut<-1.5 #Cut off in low risk only strategies

#Cancer size cut-points
ca_size_cut <- c(0.025, 5, 10, 15, 20, 30, 128) #Size cut-points for deciding stage

##########False Positive and Overdiagnosis parameters################
recall_rate <- 0.031 #UK false-positive rate
biopsy_rate <- 0.506 #Proporiton of referrals without cancer that have biopsy

#### Drug data ####

# First bring in log hazard ratios from networked analysis
loghaz_ests <- readRDS("Data/PreventionOutputs.RDS")
efficacy_ests <- loghaz_ests[1]
dropout_ests <- loghaz_ests[4]

# Extract parameters for multivariate normal draws
efficacy_mu <- efficacy_ests$AnyBC$means %>% as.numeric()
efficacy_sigma <- efficacy_ests$AnyBC$vcov %>% as.matrix()
dropout_mu <- dropout_ests$Adherence$means %>% as.numeric()
dropout_sigma <- dropout_ests$Adherence$vcov %>% as.matrix()

# Fit a Weibull distribution to data in Incidence_Mortality. Drug acts to change scale parameter.
weibull_fit <- sample(Incidence_Mortality$age,
                      size=100000,
                      prob=Incidence_Mortality$BC_age,
                      replace=TRUE) %>% fitdistr("weibull",lower=c(0,0))
inc_scale <- weibull_fit$estimate["scale"]
inc_shape <- weibull_fit$estimate["shape"]

ana_eff <- exp(efficacy_ests$AnyBC$means$Anastrozole)
tam_eff <- exp(efficacy_ests$AnyBC$means$Tamoxifen)

full_course_len <- 5

# Assume constant drop out rate with 77% of individuals reaching 5yr mark
tam_completion_prob <- .77

# Estimate Anastrozole completion probability from Tamoxifen estimate and hazard ratios:
ana_completion_prob <- exp(dropout_ests$Adherence$means$Anastrozole - dropout_ests$Adherence$means$Tamoxifen) * tam_completion_prob

completion_prob <- c(ana_completion_prob, tam_completion_prob)

# Now estimate per-unit-time dropout rates based on exponential time to dropout:
tam_dropout_rate <- (1. / full_course_len) * log(1 / (tam_completion_prob))
ana_dropout_rate <- (1. / full_course_len) * log(1 / (ana_completion_prob))

# Work out mean time taking each drug
mean_tam_length <- full_course_len * (1 - tam_completion_prob) / log(1 / tam_completion_prob)
mean_ana_length <- full_course_len * (1 - ana_completion_prob) / log(1 / ana_completion_prob)

# Quick check: quantities below give efficacy of taking full five-year course
# assuming linear relationship between time taking and hazard ratio. If both of
# these are less than one then the linear model is safe to use because no one
# goes past this point.
tam_full_course_eff <- 1 - (1 - tam_eff) * log(1 / tam_completion_prob) / (1 - tam_completion_prob)
ana_full_course_eff <- 1 - (1 - ana_eff) * log(1 / ana_completion_prob) / (1 - ana_completion_prob)
if ((tam_full_course_eff>1)|(ana_full_course_eff>1)){
  print("Assumption of linear change to hazard ratio with time taking drug will
        not work for one or both drugs being simulated.")
}

course_length <- c(5., 5.)

#Assign women to risk groups based on 10yr risk if using risk-stratified approach  
if(screen_strategy==1 | screen_strategy==9) {
  risk_red <- matrix(c(ana_eff, tam_eff,
                       ana_eff, tam_eff,
                       ana_eff, tam_eff,
                       ana_eff, tam_eff,
                       ana_eff, tam_eff),
                     nrow = 5,
                     ncol = 2)
  
  course_length <- c(5., 5.)
  
  uptake <-rbind(c(0., 0.),
                 c(0., 0.),
                 c(0., 0.),
                 c(.71, .71),
                 c(.71, .71))
  
  persistence <- matrix(c(ana_dropout_rate, tam_dropout_rate,
                          ana_dropout_rate, tam_dropout_rate,
                          ana_dropout_rate, tam_dropout_rate,
                          ana_dropout_rate, tam_dropout_rate,
                          ana_dropout_rate, tam_dropout_rate),
                        nrow = 5,
                        ncol = 2)
} else
  if(screen_strategy==2) {
    risk_red <- matrix(c(ana_eff, tam_eff,
                         ana_eff, tam_eff,
                         ana_eff, tam_eff),
                       nrow = 3,
                       ncol = 2)
    
    uptake <-rbind(c(0., 0.),
                   c(0., 0.),
                   c(.71, .71))
    
    persistence <- matrix(c(ana_dropout_rate, tam_dropout_rate,
                            ana_dropout_rate, tam_dropout_rate,
                            ana_dropout_rate, tam_dropout_rate),
                          nrow = 3,
                          ncol = 2)
  } else
    if(screen_strategy==7 | screen_strategy==8) {
      risk_red <- matrix(c(ana_eff, tam_eff,
                           ana_eff, tam_eff),
                         nrow = 2,
                         ncol = 2)
      
      uptake <-rbind(c(0., 0.),
                     c(.71, .71))
      
      persistence <- matrix(c(ana_dropout_rate, tam_dropout_rate,
                              ana_dropout_rate, tam_dropout_rate),
                            nrow = 2,
                            ncol = 2)
    }  else{
      risk_red <- matrix(c(ana_eff, tam_eff),
                         nrow = 1,
                         ncol = 2)
      
      uptake <-matrix(c(0., 0.),
                      nrow = 1,
                      ncol = 2)
      
      persistence <- matrix(c(ana_dropout_rate, tam_dropout_rate),
                            nrow = 1,
                            ncol = 2)
    }

age_prescribed <- 50

median_age_at_men <- 51
prob_premen <- exp(- age_prescribed * (log(2) / median_age_at_men)) # Assuming exponential distribution (not correct!)

cost_in_full_courses <- TRUE # If TRUE then each person to be prescribed drug incurs cost of full course, otherwise cost is proportional to time taking

#######################Cost Data#########################################

cost_strat<-7.40 #Cost of risk prediction
cost_screen_base <- 39.93 #Cost of Mammography
cost_follow_up_base <- 130.97 #Cost of follow-up
cost_biop_base <- 558 #Cost of biopsyy
cost_DCIS_base <- 12346.83 #Cost of treating DCIS
cost_US_base <- 102.00 #Cost of ultrasound
cost_MRI_base <-162.00 #Cost of MRI
cost_drug_base <- c(100., 100.) # Cost of full course of drug

#If deterministic analysis then set costs as base costs
if(PSA==0){
  cost_DCIS<-cost_DCIS_base
  cost_screen<-cost_screen_base
  cost_follow_up <- cost_follow_up_base
  cost_biop <- cost_biop_base
  cost_US <- cost_US_base
  cost_MRI <-cost_MRI_base
  cost_drug <- cost_drug_base
}

#Set up look-up table for treatment costs
tbl <- tribble(~Yr, ~Early_18.64, ~Late_18.64, ~Diff1, ~Early_65plus, ~Late_65plus, ~Diff2,
               0, 464, 607, 143, 1086, 1324, 238,
               1, 10746, 13315, 2569, 7597, 8804, 1207,
               2, 3357, 5785, 2429, 2529, 3650, 1121,
               3, 1953, 3782, 1829, 2156, 3170, 1014,
               4, 1627, 2932, 1305, 2230, 2924, 693,
               5, 1617, 2841, 1225, 2077, 2957, 880,
               6, 1547, 2645, 1099, 2174, 2783, 609,
               7, 1394, 2618, 1225, 2063, 2903, 840,
               8, 1376, 2559, 1183, 2134, 2454, 320,
               9, 1279, 1848, 569, 2204, 2932, 728) %>%
  dplyr::select(-Diff1, -Diff2) %>%
  pivot_longer(cols      = contains("6"),
               names_to  = c("Stage", "Age"),
               names_sep = "_",
               values_to = "Cost") %>%
  group_by(Stage, Age) %>%
  mutate(DCost      = Cost - first(Cost),
         DCost.i    = DCost * 1.402093, # NHSCII inflator for 2010/11-->2023/2024
         disc       = 1/1.035^(Yr-0.5),
         DCost.i.d  = DCost.i * disc,
         CDCost.i.d = cumsum(DCost.i.d),
         Yr1        = as.factor(Yr==1),
         Yr2        = as.factor(Yr==2),
         Yr3        = as.factor(Yr==3)) %>%
  filter(Yr > 0) %>%
  arrange(Stage, Age, Yr)

#Create predictive model of cost by age of diagnosis, stage, life expectancy
mod <- lm(data = tbl,
          formula = log(DCost) ~ (Yr1 + Yr2 + Yr3 + Yr) * Stage * Age)

#Prediction matrix
tblNewDat <- crossing(Yr=1:50, Stage=c("Early", "Late"), Age=c("18.64", "65plus")) %>%
  mutate(Yr1 = as.factor(Yr==1),
         Yr2 = as.factor(Yr==2),
         Yr3 = as.factor(Yr==3))

#Generate cost predictions
tblNewDat %>%
  bind_cols(pred = mod %>% predict(newdata = tblNewDat)) %>%
  mutate(DCost.p = exp(pred)) -> tblPred

#Make lookup table for costs
tblLookup <- tblPred %>%
  filter(Yr==1) %>%
  mutate(across(c(Yr, pred, DCost.p), ~0)) %>%
  bind_rows(tblPred) %>%
  group_by(Stage, Age) %>%
  mutate(DCost.p.i    = DCost.p * 1.402093, # NHSCII inflator for 2010/11-->2023/2024
         disc         = 1/1.035^(Yr-0.5),
         DCost.p.i.d  = DCost.p.i * disc,
         CDCost.p.i.d = cumsum(DCost.p.i.d),
         StageEarly   = Stage=="Early",
         AgeYoung     = Age=="18.64") %>%
  arrange(Stage, Age, Yr) %>%
  ungroup()



#######################Utility Weights#########################################

#Set age adjusted utility values
utility_ages<-read.csv("Data/age_related_utilities.csv")

#Set time independent utility decrements
#Utility of DCIS
utility_DCIS <- 1 #assumes no effect

#Set first year cancer utilities: 
utility_stage_cat_y1 <- c("stage1"=0.82/0.822, 
                          "stage2"=0.82/0.822,
                          "stage3"=0.75/0.822,
                          "Metastatic"=0.75/0.822,
                          "DCIS"=utility_DCIS)

#Set following year cancer utilities:
utility_stage_cat_follow <- c("stage1"=0.82/0.822,
                              "stage2"=0.82/0.822,
                              "stage3"=0.75/0.822,
                              "Metastatic"=0.75/0.822,
                              "DCIS"=utility_DCIS)